CellFE
Atlanta, US · Founded 2018 · 20 employees on LinkedIn · 6 known investors
CellFE develops microfluidics technology and instrumentation for cell therapy manufacturing, serving biotech researchers and clinical teams. The company's platform enables more efficient and accessible production of cell therapies for treatment applications.
Founders & leadership
Investors · 6
Funding
SEC filings, press & company announcements$22M disclosed across 1 round · 2023
- $22MSeries ASep 2023 · 3 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does CellFE do?
- CellFE develops microfluidics technology and instrumentation for cell therapy manufacturing, serving biotech researchers and clinical teams. The company's platform enables more efficient and accessible production of cell therapies for treatment applications.
- Who founded CellFE?
- CellFE was founded by Alla Zamarayeva, PhD, Todd Sulchek, PhD, Alex Alexeev, PhD, Alla Zamarayeva, Todd Sulchek, Alex Alexeev in 2018.
- Who are CellFE's investors?
- CellFE's investors include Dynamk Capital, Cota Capital, GreatPoint Ventures, M Ventures, Embark Ventures, Khosla Ventures.
- How much funding has CellFE raised?
- CellFE has disclosed $22M raised across 1 round.
- Where is CellFE headquartered?
- CellFE is headquartered in Atlanta, US.

